Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2011
06/15/2011EP2331523A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
06/15/2011EP2331522A2 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
06/15/2011EP2331511A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
06/15/2011EP2331506A1 Novel benzamides, production thereof, and use thereof as medicaments
06/15/2011EP2331503A1 4-phenoxymethylpiperidines as modulators of gpr119 activity
06/15/2011EP2331500A1 Pyrrolidine n-benzyl derivatives
06/15/2011EP2331499A1 Cold menthol receptor antagonists
06/15/2011EP2331095A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
06/15/2011EP2330891A1 Fungicidal pyridazines
06/15/2011EP2203430B1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
06/15/2011EP2074086B1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
06/15/2011EP1937664B1 Hydrazide compound and pesticidal use of the same
06/15/2011EP1937650B1 Heterocyclic compounds
06/15/2011EP1784399B1 Pyrimidine derivatives
06/15/2011EP1771454B1 Hepatitis c inhibitor peptide analogs
06/15/2011EP1717229B1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
06/15/2011EP1664022B1 2-substituted benzimidazole piperidine analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
06/15/2011EP1622616B1 Inhibitors of akt activity
06/15/2011EP1619185B1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
06/15/2011EP1175400B1 Renin inhibitors
06/15/2011EP1052254B1 Nitrogenous heterocyclic derivatives and medicine thereof
06/15/2011CN1956964B Tetrahydro-indazole cannabinoid modulators
06/15/2011CN1946714B Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
06/15/2011CN1930145B Cycloalkanopyridine derivative
06/15/2011CN1926129B Double amide insecticides
06/15/2011CN1918129B Therapeutic agent
06/15/2011CN1896066B Preparation method of Insecticide
06/15/2011CN102099423A Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter
06/15/2011CN102099357A Carboxamide compounds for the treatment of metabolic disorders
06/15/2011CN102099354A Azole compound
06/15/2011CN102099353A Hepatitis c virus inhibitors
06/15/2011CN102099352A STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
06/15/2011CN102099351A 3-heterocyclic substituted indole derivatives and methods of use thereof
06/15/2011CN102099342A Aminotetrahydroindazoloacetic acids
06/15/2011CN102099341A Aminotetrahydroindazoloacetic acids
06/15/2011CN102099340A Heterocyclic compounds as factor IXA inhibitors
06/15/2011CN102099339A Benzazepine derivatives and their use as hstamine h3 antagonists
06/15/2011CN102099031A Substituted indolyl and indazolyl derivatives and uses thereof
06/15/2011CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
06/15/2011CN102093340A Preparation method and application of 2-methylindazole derivatives
06/15/2011CN102093339A Preparation method and application of pyrimidine derivatives
06/15/2011CN102093338A N-acyl cyclic urea derivative and preparation method thereof
06/15/2011CN102093337A Preparation method of acetyl benzimidazole pyridine salt
06/15/2011CN102093336A Method for extracting alkaloid by utilizing waste water and sludge of tobaccos
06/15/2011CN102093335A Acylhydrazone and hydrazide derivatives and application thereof
06/15/2011CN102093286A Acrylic acid endothelin receptor antagonist as well as preparation method and application thereof
06/15/2011CN102093285A Cyclic amide derivatives, and their production and use as antithrombotic agents
06/15/2011CN102093260A Stereospecific synthesis of piperidine derivative
06/15/2011CN101596191B Method for treatment of disease using malonyl-coa decarboxylase inhibitor
06/15/2011CN101376663B 6-benzimidazole-pyridine-2- formiate amide metal complexe, preparation and use
06/15/2011CN101230067B Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
06/15/2011CN101177385B Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease
06/15/2011CN101104598B Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives
06/15/2011CN101094847B Aryloxy-substituted benzimidazole derivatives
06/15/2011CN101056855B Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
06/14/2011US7960570 Small molecule inhibitors of rotamase enzyme activity
06/14/2011US7960560 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
06/14/2011US7960552 6-[4-({[3-(2,6-Dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-2-quinolinecarboxylic acid and the potassium salt; antidiabetic agents; improved glucose tolerance and decreased insulin resistance
06/14/2011US7960544 Useful indole compounds
06/14/2011US7960413 Pyrazole compounds
06/14/2011US7960411 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
06/14/2011US7960409 e.g. 4-(3-fluorophenyl)-7-({4-[1-hydroxy-1-(trifluoromethyl)propyl]-1H-1,2,3-triazol-1-yl}methyl)-2H-chromen-2-one; leukotriene biosynthesis and 5-lipoxygenase (5-LO); inhibitor; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents
06/14/2011US7960404 Spirocyclic cyclohexane compounds
06/14/2011US7960402 Carbamoyl-substituted spiro derivative
06/14/2011US7960399 Quinazolinone derivatives useful as vanilloid antagonists
06/14/2011US7960398 Potent inhibitors of TNF activity
06/14/2011US7960394 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
06/14/2011US7960393 Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2
06/14/2011US7960392 Nitrogen-containing heterocyclic compounds
06/14/2011US7960387 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses
06/14/2011US7960386 Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor
06/14/2011US7960383 Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
06/14/2011US7960380 Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators
06/14/2011US7960365 Compounds with medicinal effects due to interaction with the glucocorticoid receptor
06/14/2011CA2643177C Multi-cyclic compounds for treating cancer
06/14/2011CA2564442C 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
06/14/2011CA2534921C Aminotriazole compounds useful as inhibitors of protein kinases
06/14/2011CA2499903C Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
06/14/2011CA2495661C Inhibition of phosphoinositide 3-kinase beta
06/14/2011CA2494962C Tyrosine kinase inhibitors
06/14/2011CA2494061C Protein tyrosine kinase inhibitors
06/14/2011CA2480678C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in medicine
06/14/2011CA2478232C Heterocyclic amide derivatives as cytokine inhibitors
06/14/2011CA2465328C Piperidines
06/14/2011CA2456235C Heterocyclylarylsulphonamides
06/14/2011CA2445322C Use of the abc expression promoting agent pioglitazone for the treatment of arteriosclerosis obliterans
06/14/2011CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers
06/09/2011WO2011068898A1 Protein kinase c inhibitors and uses thereof
06/09/2011WO2011068821A1 Benzimidazole inhibitors of leukotriene production
06/09/2011WO2011068561A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/09/2011WO2011068560A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/09/2011WO2011068211A1 2-pyridone compounds
06/09/2011WO2011068204A1 Benzo[c]carbazole compound that has substituent bearing pyridine ring, and organic electroluminescent element
06/09/2011WO2011068187A1 Quinazoline derivatives
06/09/2011WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives
06/09/2011WO2011067365A1 Benzpyrazole derivatives as inhibitors of p13 kinases
06/09/2011WO2011067364A1 Novel compounds
06/09/2011WO2011067306A1 Cyclohexane derivatives as inhibitors of acetyl-coa carboxylase (acc)
06/09/2011WO2011067273A1 Tetrahydroquinoline indole derivatives as monoamine reuptake inhibitors
06/09/2011WO2011019634A3 Aryl substituted sulfonamide compounds and their use as anticancer agents